MedTrace Logo

Vitamin D and Cardiovascular Events in Rheumatoid Arthritis

NCT02932644 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2016-10-13

No results posted yet for this study

Summary

The aim of the study is to evaluate cardiovascular events during long-term follow-up in Rheumatoid Arthritis. The primary outcome "any cardiovascular event" will be evaluated using systematic audits of patient records, and will be associated to low levels of vitamin D at baseline, to investigate the hypothesis that low levels of vitamin D can be part of a prediction model for cardiovascular disease in Rheumatoid Arthritis.

Conditions

Interventions

OTHER

Baseline serum vitamin D level below 50 nmol/l

There is no medical intervention. The two groups are simple allocated depending on serum levels of D-total at the time of diagnosis

OTHER

Baseline serum vitamin D level at or above 50 nmol/l

There is no medical intervention. The two groups are simple allocated depending on serum levels of D-total at the time of diagnosis

Sponsors & Collaborators

  • The Danish Rheumatism Association

    collaborator OTHER

  • University of Southern Denmark

    collaborator OTHER

  • Region of Southern Denmark

    collaborator OTHER

  • Pfizer

    collaborator INDUSTRY

  • Odense Patient Data Explorative Network

    collaborator OTHER

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Torkell Ellingsen, MD, Phd · Odense University Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-10-31
Primary Completion
2016-10-31
Completion
2016-10-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02932644 on ClinicalTrials.gov